INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SEC FORM 4/Open-market saleVerified data

Radhakrishnan Srikanth sold LUNG

Chief Science &Techn. Officer · Pulmonx Corp · Common Stock

Side
SELL
Value
$9,192
Shares
5,969
Price
$1.54
Executed
Jun 1, 2026
Disclosed
Jun 3, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 1 executedJun 3, 2026 disclosed

LUNG · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
17/ 100 · ROUTINE
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+1 / 25

    $9K reported value · 1.8% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+4 / 15

    4 prior trades recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · LUNG

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    14
    RS
    Radhakrishnan SrikanthChief Science & Techn. Officer
    LUNGPulmonx Corp
    Open-market sale
    		SELL$4,793
    2,121 sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    14
    RS
    Radhakrishnan SrikanthChief Science & Techn. Officer
    LUNGPulmonx Corp
    Open-market sale
    		SELL$5,973
    2,643 sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    14
    RS
    Radhakrishnan SrikanthChief Science & Techn. Officer
    LUNGPulmonx Corp
    Open-market sale
    		SELL$13K
    5,863 sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    14
    RS
    Radhakrishnan SrikanthChief Science & Techn. Officer
    LUNGPulmonx Corp
    Open-market sale
    		SELL$8,177
    3,618 sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    21
    ST
    Sullivan TiffanyDirector
    LUNGPulmonx Corp
    Grant or award
    		A—
    40.0K sh
    		Jun 5, 2026Jun 9, 2026
    traded Jun 5, 2026
    		+4dSEC FORM 4

    Evidence

    17
    MG
    Melenikiotou GeorgiaDirector
    LUNGPulmonx Corp
    Grant or award
    		A—
    40.0K sh
    		Jun 5, 2026Jun 9, 2026
    traded Jun 5, 2026
    		+4dSEC FORM 4

    Evidence

    17
    RS
    Radhakrishnan SrikanthChief Science &Techn. Officer
    LUNGPulmonx Corp
    Open-market sale
    		SELL$3,316
    2,153 sh
    		Jun 1, 2026Jun 3, 2026
    traded Jun 1, 2026
    		+2dSEC FORM 4

    Evidence

    17
    RS
    Radhakrishnan SrikanthChief Science &Techn. Officer
    LUNGPulmonx Corp
    Open-market sale
    		SELL$5,673
    3,684 sh
    		Jun 1, 2026Jun 3, 2026
    traded Jun 1, 2026
    		+2dSEC FORM 4

    Evidence

    17
    RS
    Radhakrishnan SrikanthChief Science &Techn. Officer
    LUNGPulmonx Corp
    Open-market sale
    		SELL$4,144
    2,691 sh
    		Jun 1, 2026Jun 3, 2026
    traded Jun 1, 2026
    		+2dSEC FORM 4

    Evidence

    21
    RS
    Radhakrishnan SrikanthChief Science &Techn. Officer
    LUNGPulmonx Corp
    Open-market sale
    		SELL$4,387
    3,068 sh
    		Mar 2, 2026Mar 4, 2026
    traded Mar 2, 2026
    		+2dSEC FORM 4

    Evidence

    21
    RS
    Radhakrishnan SrikanthChief Science &Techn. Officer
    LUNGPulmonx Corp
    Open-market sale
    		SELL$3,519
    2,461 sh
    		Mar 2, 2026Mar 4, 2026
    traded Mar 2, 2026
    		+2dSEC FORM 4

    Evidence

    21
    RS
    Radhakrishnan SrikanthChief Science &Techn. Officer
    LUNGPulmonx Corp
    Open-market sale
    		SELL$1,081
    756 sh
    		Mar 2, 2026Mar 4, 2026
    traded Mar 2, 2026
    		+2dSEC FORM 4

    Evidence

    21
    RS
    Radhakrishnan SrikanthChief Science &Techn. Officer
    LUNGPulmonx Corp
    Open-market sale
    		SELL$6,003
    4,198 sh
    		Mar 2, 2026Mar 4, 2026
    traded Mar 2, 2026
    		+2dSEC FORM 4

    Evidence

    21
    RS
    Radhakrishnan SrikanthChief Science &Techn. Officer
    LUNGPulmonx Corp
    Grant or award
    		A—
    175.0K sh
    		Mar 2, 2026Mar 4, 2026
    traded Mar 2, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002098678-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jun 1, 2026
    Published
    Jun 3, 2026
    Ingested by INSIDER
    Nov 5, 03:55 UTC
    Last re-read
    Nov 5, 03:55 UTC

    Extracted facts

    Filer
    Radhakrishnan Srikanth
    Role
    Chief Science &Techn. Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    Pulmonx Corp
    Ticker
    LUNG
    Shares
    5,969
    Price per share
    $1.54
    Value
    $9,192
    Execution date (reported)
    Jun 1, 2026
    Owned after transaction
    331.2K shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 5,969
    • Price: $1.54

    = $9,192

    What this establishes

    Radhakrishnan Srikanth filed this Form 4 reporting a open-market sale of LUNG on Jun 1, 2026. It became public on Jun 3, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Science &Techn. Officer
    Radhakrishnan Srikanthcik:0002098678
    Issuer
    Pulmonx Corpcik:0001127537

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.